E1A gene expression induces susceptibility to killing by NK cells following immortalization but not adenovirus infection of human cells.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Virology

• Publication date

  1995-07-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/VIRO.1995.1358PMID 7618277
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endogenous expression of E1A in human cells enhances the effect of adenovirus E3 on class I major histocompatibility complex antigen expression

  1993cited by this paper
• E1A oncogene expression level in sarcoma cells: an independent determinant of cytolytic susceptibility and tumor rejection.

  1993cited by this paper
• Adenovirus early region 4 and viral DNA synthesis.

  1993cited by this paper
• The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins.

  1992cited by this paper
• E1A oncogene induction of cytolytic susceptibility eliminates sarcoma cell tumorigenicity.

  1991cited by this paper
• The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells

  1991cited by this paper
• Antioncogenic effect of adenovirus E1A in human tumor cells.

  1991cited by this paper
• Evidence for interaction of different eukaryotic transcriptional activators with distinct cellular targets

  1990cited by this paper
• Resistance of human cells to the adenovirus E3 effect on class I MHC antigen expression. Implications for antiviral immunity.

  1990cited by this paper
• Role of tumor necrosis factor-alpha in E1A oncogene-induced susceptibility of neoplastic cells to lysis by natural killer cells and activated macrophages.

  1989cited by this paper
• Adenovirus persistence in man. Defective E1A gene product targeting of infected cells for elimination by natural killer cells.

  1989cited by this paper
• A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor.

  1988cited by this paper
• Viral infections in pediatric bone marrow transplant patients

  1988cited by this paper
• Differential distribution of the adenovirus E1A proteins and colocalization of E1A with the 70-kilodalton cellular heat shock protein in infected cells

  1988cited by this paper
• Adenovirus early region 1A modulation of interferon antiviral activity

  1987cited by this paper
• Adenovirus E1A gene induction of susceptibility to lysis by natural killer cells and activated macrophages in infected rodent cells

  1987cited by this paper
• Productive infection of cultured human lymphoid cells by adenovirus

  1987cited by this paper
• Expression of adenovirus E1B mutant phenotypes is dependent on the host cell and on synthesis of E1A proteins

  1987cited by this paper
• Adenoviral infections in pediatric liver transplant recipients.

  1987cited by this paper
• "E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens.

  1987cited by this paper
• Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase.

  1986cited by this paper
• Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy

  1986cited by this paper
• Sequence-specific activation of transcription by adenovirus EIa products is observed in HeLa cells but not in 293 cells

  1986cited by this paper
• Regulation of virus infections by natural killer cells. A review.

  1986cited by this paper
• Expression of the adenovirus E1A oncogene during cell transformation is sufficient to induce susceptibility to lysis by host inflammatory cells.

  1986cited by this paper
• X‐Linked Agammaglobulinemia: An Analysis of 96 Patients

  1985cited by this paper
• Transient gene expression control: effects of transfected DNA stability and trans-activation by viral early proteins

  1985cited by this paper
• Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products

  1985cited by this paper
• Isolation and analysis of adenovirus type 5 mutants containing deletions in the gene encoding the DNA-binding protein

  1985cited by this paper
• Rapid intracellular turnover of adenovirus 5 early region 1A proteins

  1984cited by this paper
• Adenovirus 2 early region 1A stimulates expression of both viral and cellular genes.

  1984cited by this paper
• A cell line that supports the growth of a defective early region 4 deletion mutant of human adenovirus type 2.

  1983cited by this paper
• Cell surface phenotype of a cloned line of human natural killer cells.

  1982cited by this paper
• Deletion mutants of adenovirus 2: isolation and initial characterization of virus carrying mutations near the right end of the viral genome.

  1981cited by this paper
• Adenovirus infection in the immunocompromised patient.

  1980cited by this paper
• High nonspecific reactivity of normal lymphocytes against rnycoplasma‐infected target cells in cytotoxicity assays

  1979cited by this paper
• Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells.

  1979cited by this paper
• Analysis of human tonsil and cancer DNAs and RNAs for DNA sequences of group C (serotypes 1, 2, 5, and 6) human adenoviruses.

  1979cited by this paper
• Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

  1977cited by this paper
• The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness.

  1969cited by this paper

• Named Entity Recognition and Relation Detection for Biomedical Information Extraction

  2020cites this paper
• E1A oncogene induced sensitization to NK cell induced apoptosis requires PIDD and Caspase-2

  2019cites this paper
• Advances and perspectives in gene-based therapy for breast cancer

  2007cites this paper
• The interaction of adenovirus E1A with p300 family members modulates cellular gene expression to reduce tumorigenicity

  2007cites this paper
• Measurement of natural-killer cell lytic activity of adenovirus-infected or adenovirus-transformed cells.

  2007cites this paper
• Adenovirus subversion of immune surveillance, apoptotic and growth regulatory pathways: a model for tumorigenesis.

  2006cites this paper
• Interleukin-6 in acute exercise and training: what is the biological relevance?

  2006cites this paper
• Adenovirus E1A reverses the resistance of normal primary human lung fibroblast cells to TRAIL through DR5 upregulation and caspase 8-dependent pathway

  2006cites this paper
• The implication of alterations in leukocyte subset counts on immune function.

  2006cites this paper
• Oncolytic Adenovirus-Mediated E1A Gene Therapy Induces Tumor-Cell Apoptosis and Reduces Tumor Angiogenesis Leading to Inhibition of Hepatocellular Carcinoma Growth in Animal Model

  2006cites this paper
• Adenovirus E1A gene-induced tumor cell rejection through cellular sensitization to immune and nonimmune apoptotic injuries.

  2005cites this paper
• Defective Clearance of Adenovirus in IRF‐1–/– Mice Associated with Defects in NK and T Cells but not Macrophages

  2004cites this paper
• Enhanced TRAIL sensitivity by E1A expression in human cancer and normal cell lines: inhibition by adenovirus E1B19K and E3 proteins.

  2004cites this paper
• Expression of an E1A/E7 Chimeric Protein Sensitizes Tumor Cells to Killing by Activated Macrophages but Not NK Cells

  2004cites this paper
• Evasion of the immune system by adenoviruses.

  2004cites this paper
• E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo.

  2003influential citation
• Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie der Ludwig-Maximilians-Universität München Down-modulation of the apoptosis receptor Fas and the EGF receptor by the adenovirus E3/10.4-14.5K proteins requires the concerted action of two distinct transport signals

  2003cites this paper
• Subversion of host defense mechanisms by adenoviruses.

  2002cites this paper
• Role of the E1A Rb-binding domain in repression of the NF-κB-dependent defense against tumor necrosis factor-α

  2002cites this paper
• Role of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alpha.

  2002cites this paper
• Viral Proteins Counteracting Host Defenses

  2002cites this paper
• MHC class I molecules on adenovirus E1A-expressing tumor cells inhibit NK cell killing but not NK cell-mediated tumor rejection.

  2001cites this paper
• Dissimilar immunogenicities of human papillomavirus E7 and adenovirus E1A proteins influence primary tumor development.

  2000influential citation
• Adenovirus E1A Oncogene Expression in Tumor Cells Enhances Killing by TNF-Related Apoptosis-Inducing Ligand (TRAIL)1

  2000cites this paper
• E1A oncogene-induced cellular sensitization to immune-mediated apoptosis is independent of p53 and resistant to blockade by E1B 19 kDa protein.

  1999cites this paper
• E1A oncogene induction of cellular susceptibility to killing by cytolytic lymphocytes through target cell sensitization to apoptotic injury.

  1999cites this paper
• [Antiviral immunodeficiency: EBV, CMV, adenovirus].

  1997cites this paper
• Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro

  1996cites this paper
• E1A second exon requirements for induction of target cell susceptibility to lysis by natural killer cells: implications for the mechanism of action.

  1996cites this paper
• E1A oncogene expression in target cells induces cytolytic susceptibility at a post-recognition stage in the interaction with killer lymphocytes.

  1996cites this paper
• Role of p300-family proteins in E1A oncogene induction of cytolytic susceptibility and tumor cell rejection.

  1996cites this paper
• Inhibition of IFN-stimulated gene expression and IFN induction of cytolytic resistance to natural killer cell lysis correlate with E1A-p300 binding.

  1996cites this paper
• Oncogenicity of human papillomavirus- or adenovirus-transformed cells correlates with resistance to lysis by natural killer cells

  1995cites this paper